Identification of annexin 1 as a PU.1 target gene in leukemia cells

Leukemia Research

Volumn 33, Issue 12, 2009, Pages 1658-1663

  Iseki, Yuko ^a   Imoto, Akemi ^a   Okazaki, Toshio ^a,b   Harigae, Hideo ^c   Takahashi, Shinichiro ^a,b  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AML; Annexin 1; PU.1

Indexed keywords

LIPOCORTIN 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PU 1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANNEXIN A1; BASE SEQUENCE; FLOW CYTOMETRY; HUMANS; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS;

EID: 70249109376     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.04.010     Document Type: Article

References (31)

1. Chen H.M., Zhang P., Voso M.T., Hohaus S., Gonzalez D.A., Glass C.K., et al. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85 (1995) 2918-2928
2. Scott E.W., Simon M.C., Anastasi J., and Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994) 1573-1577
3. Rosenbauer F., Wagner K., Kutok J.L., Iwasaki H., Le Beau M.M., and Okuno Y. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36 (2004) 624-630
4. Raynal P., and Pollard H.B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197 (1994) 63-93
5. Moss S.E. Ion channels. Annexins taken to task. Nature 378 (1995) 446-447
6. Rothhut B. Participation of annexins in protein phosphorylation. Cell Mol Life Sci 53 (1997) 522-526
7. Alldridge L.C., Harris H.J., Plevin R., Hannon R., and Bryant C.E. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J Biol Chem 274 (1999) 37620-37628
8. Lopez-Pedrera C., Villalba J.M., Siendones E., Barbarroja N., Gomez-Diaz C., Rodriguez-Ariza A., et al. Proteomic analysis of acute myeloid leukemia: identification of potential early biomarkers and therapeutic targets. Proteomics 6 Suppl. 1 (2006) S293-S299
9. Inomata M., Takahashi S., Harigae H., Kameoka J., Kaku M., and Sasaki T. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias. Leuk Res 30 (2006) 659-664
10. Takahashi S., Harigae H., Kameoka J., Sasaki T., and Kaku M. AML1B transcriptional repressor function is impaired by the Flt3 internal tandem duplication. Br J Haematol 130 (2005) 428-436
11. Hirosawa M., Nakahara M., Otosaka R., Imoto A., Okazaki T., and Takahashi S. The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells. Leuk Res 33 (2009) 693-699
12. Takahashi S., Harigae H., Kaku M., Sasaki T., and Licht J.D. Flt3 mutation activates p21(WAF1/CIP1) gene expression through the action of STAT5. Biochem Biophys Res Commun 316 (2004) 85-92
13. Sakurai D., Yamaguchi A., Tsuchiya N., Yamamoto K., and Tokunaga K. Expression of ID family genes in the synovia from patients with rheumatoid arthritis. Biochem Biophys Res Commun 284 (2001) 436-442
14. Pietsch A., Erl W., and Lorenz R.L. Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. Biochem Pharmacol 52 (1996) 433-439
15. Takahashi S., Harigae H., Ishii K.K., Inomata M., Fujiwara T., Yokoyama H., et al. Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6. Leuk Res 29 (2005) 893-899
16. Ishizawa K., Obara Y., Seki O., Fujimaki S., Kameoka J., Ichinohasama R., et al. Detection of bone marrow infiltration of lymphoma cells by fluorescence in situ hybridization. Clin Chim Acta 344 (2004) 79-82
17. Nogueira M.M., Mitjavila-Garcia M.T., Le Pesteur F., Filippi M.D., Vainchenker W., Dubart Kupperschmitt A., et al. Regulation of Id gene expression during embryonic stem cell-derived hematopoietic differentiation. Biochem Biophys Res Commun 276 (2000) 803-812
18. Ge Y., and Elghetany M.T. CD36: a multiligand molecule. Lab Hematol 11 (2005) 31-37
19. Miranda M.B., McGuire T.F., and Johnson D.E. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 16 (2002) 683-692
20. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science 278 (1997) 1059-1064
21. Platanias L.C. Map kinase signaling pathways and hematologic malignancies. Blood 101 (2003) 4667-4679
22. Milella M., Kornblau S.M., Estrov Z., Carter B.Z., Lapillonne H., Harris D., et al. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. J Clin Invest 108 (2001) 851-859
23. Martelli A.M., Nyakern M., Tabellini G., Bortul R., Tazzari P.L., Evangelisti C., et al. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20 (2006) 911-928
24. Gilliland D.G., and Griffin J.D. The roles of FLT3 in hematopoiesis and leukemia. Blood 100 (2002) 1532-1542
25. Takahashi S., McConnell M.J., Harigae H., Kaku M., Sasaki T., Melnick A.M., et al. The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT. Blood 103 (2004) 4650-4658
26. Wlodarski P., Zhang Q., Liu X., Kasprzycka M., Marzec M., and Wasik M.A. PU.1 activates transcription of SHP-1 gene in hematopoietic cells. J Biol Chem 282 (2007) 6316-6323
27. Kihara-Negishi F., Yamamoto H., Suzuki M., Yamada T., Sakurai T., Tamura T., et al. In vivo complex formation of PU.1 with HDAC1 associated with PU. 1-mediated transcriptional repression. Oncogene 20 (2001) 6039-6047
28. Suzuki M., Yamada T., Kihara-Negishi F., Sakurai T., Hara E., Tenen D.G., et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. Oncogene 25 (2006) 2477-2488
29. Wu Y.L., Jiang X.R., Lillington D.M., Newland A.C., and Kelsey S.M. Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance. Br J Haematol 111 (2000) 807-816
30. Torlakovic E.E., Bilalovic N., Golouh R., Zidar A., and Angel S. Prognostic significance of PU.1 in follicular lymphoma. J Pathol 209 (2006) 352-359
31. Ozeki K., Kiyoi H., Hirose Y., Iwai M., Ninomiya M., Kodera Y., et al. Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood 103 (2004) 1901-1908